Alzheimer niko upe mba'asy oporombohasyvéva, hetaiterei tapicha ohasa asy.
Prevalencia ha incidencia oĩ heta ary, sexo, raza ha ubicación geográfica.
Alzheimer Atyguasu he'iháicha, amo 5,8 sua Estados Unidos-gua oiko va'ekue Alzheimer mba'asy reheve 2020 arýpe, ha oje'e ko papapy ojupiha haimete 14 sua-pe 2050-pe.
Yvy'ape tuichakue, Organización Mundial de la Salud he'i oĩha amo 50 millón tapicha rupi ikatúva iñakãnundu, ha upéva apytépe, Alzheimer ha'e pe mba'asy ojehechavéva.
Katz MJ, Lipton RB, Hall CB, Zimmerman ME, Sanders AE, Verghese J, Dickson DW, Derby CA: Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord. , 26 (4): 335-43.
Mayeux R, Stern Y: Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med. 2012, 2 (8): .
Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003, 60 (8): 1119-22.
de Figueiredo JM: Methodological aspects of comparative research in the epidemiology of Alzheimer disease. Am J Geriatr Psychiatry. , 10 (4): 373-85.
['Ñemboyke: pohã']
["Ko página web niko ñehekombo'e ha marandu rehegua añónte, ndaha'éi ñeporandu térã ñepytyvõ pohãnohárape."]
["Ko marandu oñeme'ẽva ndojeporúi va'erã ojeikuaa térã oñepohano hag̃ua peteĩ problema de salud térã mba'asy, ha umi tapicha ohekáva consejo médico ha'eñoháme oñe'ẽva'erã peteĩ pohanohára ikatupyrýva ndive."]
["DMCA ojerure ne ñemomarandu rehe ejaposégui mba'evai ejaposéva rehe toike ko'ã mba'e: (1) tembiapo ojejaposéva rehegua ha'éva mba'evai; (2) jehaipy ha mba'ekuaarã ome'ẽva oréve jehaipyre ha'éva mba'evai ha ome'ẽva oréve pa'ũ rojuhu hag̃ua; (3) ne ñanduti veve, ne rendaite, ne pumbyry papapy ha ne ñanduti veve; (4) ñe'ẽme'ẽ erekóva rejeroviaha pe mba'evai ejaposéva rehe ndojeruréiha mba'evai apohára, imaranduhára térã léi."]
["5. peteî declaración nde rejapóva, remoîva nde réra ha remoîva'erâha nde jurúpe, umi mba'e oîva ñemomarandúpe oîmbaha añetehápe ha rerekoha pokatu remoañete haguâ umi derecho oje'éva nde rehe ojepoko vaiha;"]
["Ndoikéi ramo opaite ko'ã mba'e ikatu ombohape nde denuncia ñemboguata."]
['Ñemboheraguapy']
["Remba'eporanduséramo térã ereko hag̃ua ne remiandu ehai oréve."]
How common is alzheimer?
Alzheimer's disease is the most common form of dementia, affecting millions of people worldwide.
The prevalence and incidence rates vary by age, sex, race, and geographic location.
According to the Alzheimer's Association, an estimated 5.8 million Americans were living with Alzheimer's disease in 2020, and this number is projected to increase to nearly 14 million by 2050.
Globally, the World Health Organization estimates that around 50 million people have dementia, with Alzheimer's disease being the most common cause.
The incidence of Alzheimer's disease increases with age, and it is more common in women than in men.
Additionally, certain genetic and environmental factors may increase an individual's risk of developing the disease.
It is important to note that these numbers are estimates and may vary depending on the source and methodology used in the studies.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
["Mba'e rehegua"]
['BioMedLib oiporu computadora automatizada (algoritmo de aprendizaje automático) ojapo hag̃ua porandu ha mbohovái.']
